ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction
- 1 March 1995
- journal article
- Published by Elsevier in The Lancet
- Vol. 345 (8951), 669-685
- https://doi.org/10.1016/s0140-6736(95)90865-x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the “practical” Study)The American Journal of Cardiology, 1994
- Magnesium and myocardial infarctionThe Lancet, 1994
- Does captopril treatment before thrombolysis in acute myocardial infarction attenuate reperfusion damage? Short-term and long-term effectsInternational Journal of Cardiology, 1994
- Fourth international study of infarct survival: Protocol for a large simple study of the effects of oral mononitrate, of oral captopril, and of intravenous magnesiumThe American Journal of Cardiology, 1991
- LONG-TERM THERAPEUTIC EFFICACY WITH ONCE-DAILY ISOSORBIDE-5-MONONITRATE (IMDUR®)Journal of Clinical Pharmacy & Therapeutics, 1990
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- Effect of Intervals between Doses on the Development of Tolerance to Isosorbide DinitrateNew England Journal of Medicine, 1987
- Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.Circulation, 1982
- Tolerance to the circulatory effects of oral isosorbide dinitrate. Rate of development and cross-tolerance to glyceryl trinitrate.Circulation, 1980
- Expansion of transmural myocardial infarction: a pathophysiologic factor in cardiac rupture.Circulation, 1979